Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
Kisspeptin-10 (KISS10) is a sexual health peptide, at the clinical trials stage in the published literature. Fragment of kisspeptin that stimulates GnRH release, playing a key role in puberty initiation and reproductive function.
Fragment of kisspeptin that stimulates GnRH release, playing a key role in puberty initiation and reproductive function.
| Research Status | Clinical trials |
|---|---|
| Half-Life | ~28 minutes |
| Administration | Subcutaneous or IV injection |
| Doses Reported in Published Studies | 1-10 mcg/kg |
Activates GnRH neurons to stimulate pituitary release of LH and FSH.
Fragment of kisspeptin that stimulates GnRH release, playing a key role in puberty initiation and reproductive function.
Activates GnRH neurons to stimulate pituitary release of LH and FSH.
Kisspeptin-10 is at the following stage in the published literature: Clinical trials. All information is for research and educational purposes only.
Reported half-life: ~28 minutes.
Reported administration route in the literature: Subcutaneous or IV injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.